Eagles reportedly make $41m Saquon Barkley highest-paid running back in history
Aston Villa close on quarter-finals after Asensio piles pain on Club Brugge
Germany’s future coalition partners to relax debt rules to boost defence budget
Australia news live: Albanese in Brisbane as Tropical Cyclone Alfred remains on course to slam into Gold Coast
Chile’s perfect skies for stargazing under threat from giant chemical plant
Pembrolizumab is used to treat triple-negative form of disease but researchers say it could be used more widely
Thousands more women with breast cancer could benefit from a blockbuster immunotherapy drug than previously thought, research suggests.
Pembrolizumab, sold under the brand name Keytruda, targets and blocks a specific protein on the surface of certain immune cells that then seek out and destroy the cancerous cells.
More Stories
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’
Microsoft unveils chip it says could bring quantum computing within years
Nasa astronauts stuck in space after spacecraft problems to return to Earth